News OEM

A Success Story: Streamlining Biomaterials Manufacturing

October 25, 2019 - Spain

rHBcAg scale up

Biokit partnered with an IVD company to scale-up the production of a critical biomaterial for an IVD assay.

Recent improvements in healthcare access have led to an increase in demand for in-vitro diagnostic testing which impacts the supply chain. In order to keep up with the rising demand for IVD assays, manufacturing capabilities, especially those related to critical biomaterials, should be adapted to scale-up the process.

In Biokit, we work alongside our customers in order to overcome challenges such as increases in demand for critical biomaterials and to simplify the supply chain. 

Our Approach

In this case, the biomaterial was expressed in E. coli, which continues to be a widespread expression system thanks to its low cost, rapid culture times and high biomaterial yield. However, when scaling-up, an optimization process is needed in order to improve productivity and streamline supply chain operations.

A multifunctional team including R&D, Operations and Quality works by following a given methodology in order to fulfil customer needs.

rHBcAg Scale up 1

Outcomes 

The result of this process was an increase in production by 100×, and a 12-hour reduction in culture time (from 16 h to 4 h). Moreover, the supply chain has been streamlined thanks to obtaining bigger single batches, which reduces the number of shipments and income controls from our partners.

Scale up 2
 

scale up 3

Share Press Release:

LinkedIn twitter facebook
Contact us

Please contact us directly via telephone or with the following form.

Tel. +34 93 860 90 00

DATA PROTECTION POLICY:

Biokit, S.A. and Biokit Research & Development, S.L.U. will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO-biokit@werfen.com.